靶点针对疾病信息20(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
TARGNAME
Mesothelin (MSLN)
INDICATI
Phase 2 Peritoneal cancer [ICD-11: 2C51]
INDICATI
Phase 2 Stomach cancer [ICD-11: 2B72]
INDICATI
Phase 1/2 Cervical cancer [ICD-11: 2C77]
INDICATI
Phase 1/2 Liver cancer [ICD-11: 2C12]
INDICATI
Phase 1/2 Lung cancer [ICD-11: 2C25]
INDICATI
Phase 1/2 Non-small cell lung cancer [ICD-11: 2C25]
INDICATI
Phase 1 Breast cancer [ICD-11: 2C60-2C6Y]
INDICATI
Phase 1 Endometrial cancer [ICD-11: 2C76]
INDICATI
Phase 1 Fallopian tube cancer [ICD-11: 2C74]
INDICATI
Phase 1 Lymphatic vessel/lymph nodes disorder [ICD-11: BD9Z]
INDICATI
Phase 1 Mesothelial tumour [ICD-11: 2F10]
INDICATI
Phase 1 Mesothelin positive tumour [ICD-11: 2C51-2F10]
INDICATI
Phase 1 Metastatic malignant neoplasm [ICD-11: 2D50-2E09]
INDICATI
Phase 1 Metastatic pleura neoplasm [ICD-11: 2D72]
INDICATI
Phase 1 Pleural mesothelioma [ICD-11: 2C26]